Top Midday Gainers

MT newswire2026/10/08 18:30

02:30 PM EDT, 10/08/2026 (MT Newswires) -- Viatris (VTRS) agreed to acquire Pacira BioSciences (PCRX) in an all-cash deal worth roughly $1.65 billion to strengthen its non-opioid pain management portfolio, according to a statement released Thursday. Pacira shares soared 44%, with intraday trading volume catapulting to more than 24.4 million from a daily average of about 589,000. Haemonetics (HAE) said in a filing Thursday that CSL Plasma expects to complete the rollout of Haemonetics' devices and disposables by the end of 2027. Shares climbed 16% as intraday trading volume rose to over 1.90 million, versus a daily average of roughly 679,000. UBS adjusted its price target on XP (XP) to $37 from $25 while keeping its buy rating for the stock. XP shares jumped 4% as intraday trading volume rose to over 8.59 million from a daily average of about 6.87 million. Price: 17.35, Change: -0.14, Percent Change: -0.80

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

NEAR Price Falls 8.14% as Analyst Eyes Buys Below $3.50 Level

CoinCryptoNewz•2026/11/07 05:03

Goldman Sachs expects $7.5 billion in buying of gold and silver in January next year, while crude oil faces selling pressure of $7.9 billion.

金十数据•2026/11/07 03:47

Pyth October Report: ARR Jumps 18.9% as Data Expansion Accelerates

Coinpedia•2026/11/07 03:27

Elon Musk: SpaceX (SPCX.US) Q4 revenue is expected to increase by approximately 70% quarter-on-quarter, with government contract income share falling below 10%

Elon Musk stated on Friday that SpaceX (SPCX.US) will continue to reduce its dependence on U.S. government procurement contracts.

智通财经•2026/11/07 02:16